Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 15/05/2026
In
Objective
To generate long-term capital appreciation by investing in a globally diversified portfolio of healthcare companies, to include, but not limited to, pharmaceutical, biotechnology, medical device and healthcare services companies.
AIC sector
Management group
Company website
Launch date
15/06/2010
September
Domicile
United Kingdom
Fund manager
David Pinniger, James Douglas, Deane Donnigan, Gareth Powell
Dividend frequency
Semi-Annually
Wind-up provisions
The Board intends to review the Company’s future and may propose alternative arrangements for shareholder approval before the 2026 AGM. If not approved, a resolution to liquidate the Company will be proposed at the 2026 AGM.
441.12
| Share type | Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Share | 386.12 | 401.12 | 385.00 | 399.96 | -3.74 | 9 | 0.57 | Feb, Aug | 0.9 (30/09/2025) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 05/02/2026 | 27/02/2026 | 1.000 | No | 2025 |
| 07/08/2025 | 29/08/2025 | 1.200 | No | 2025 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Polar Capital Global Healthcare | Share price total return | 24.6 | 14.7 | 56.3 | 150.3 |
| Biotechnology & Healthcare AIC sector | Share price total return | N/A | N/A | N/A | N/A |
Scroll
Share structure
23,859,256
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Polar Capital Glb Healthcare Ord Total | 239,835 | 7,239,010 | 114,618,761 | 312,181,558 |
| Polar Capital Glb Healthcare Ord Average | N/A | 344,715 | 453,039 | 247,370 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Polar Capital Glb Healthcare Ord Total | 0.92 | 27.83 | 447.07 | 1,104.14 |
| Polar Capital Glb Healthcare Ord Average | N/A | 1.33 | 1.77 | 0.87 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GB00B6832P16 | PCGH | GBX | London Stock Exchange - MAIN Chi-x Europe Limited London Stock Exchange |
Scroll
Top holdings
Data as at : 31/03/2026
| Investment | % of total assets |
|---|---|
| Eli Lilly and Co | 8.6 |
| AstraZeneca PLC | 6.4 |
| Roche Holding AG Ordinary Shares new | 5.2 |
| Thermo Fisher Scientific Inc | 4.9 |
| CVS Health Corp | 4.7 |
| Teva Pharmaceutical Industries Ltd ADR | 4.6 |
| The Cigna Group | 4.0 |
| Fresenius SE & Co KGaA | 3.4 |
| Novo Nordisk AS Class B | 3.2 |
| UCB SA | 2.9 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
